BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 14676676)

  • 1. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
    Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
    FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
    Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
    J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-complement strategies in experimental sepsis.
    Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
    Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A key role of C5a/C5aR activation for the development of sepsis.
    Riedemann NC; Guo RF; Ward PA
    J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a functional role of the second C5a receptor C5L2.
    Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
    FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of C5a in the innate immune response after experimental blunt chest trauma.
    Flierl MA; Perl M; Rittirsch D; Bartl C; Schreiber H; Fleig V; Schlaf G; Liener U; Brueckner UB; Gebhard F; Huber-Lang MS
    Shock; 2008 Jan; 29(1):25-31. PubMed ID: 17621257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.
    Nishiura H; Zhao R; Yamamoto T
    J Biochem; 2011 Sep; 150(3):271-7. PubMed ID: 21613290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo regulation of neutrophil apoptosis by C5a during sepsis.
    Guo RF; Sun L; Gao H; Shi KX; Rittirsch D; Sarma VJ; Zetoune FS; Ward PA
    J Leukoc Biol; 2006 Dec; 80(6):1575-83. PubMed ID: 16997861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional identification of the stable transfection C5aR cell line Molt-4.
    Zhang C; Xu R; Wang J; Han G; Chen G; Wang R; Wei H; Shen B; Ma Y; Li Y
    Cell Mol Immunol; 2007 Dec; 4(6):461-5. PubMed ID: 18163958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a, a therapeutic target in sepsis.
    Guo RF; Ward PA
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a receptor and thymocyte apoptosis in sepsis.
    Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
    FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of C5a blockade in sepsis.
    Czermak BJ; Sarma V; Pierson CL; Warner RL; Huber-Lang M; Bless NM; Schmal H; Friedl HP; Ward PA
    Nat Med; 1999 Jul; 5(7):788-92. PubMed ID: 10395324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor.
    van den Berg CW; Tambourgi DV; Clark HW; Hoong SJ; Spiller OB; McGreal EP
    J Immunol; 2014 Feb; 192(4):1787-95. PubMed ID: 24446515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.